Canaccord lowered the firm’s price target on Edgewell Personal Care (EPC) to $32 from $35 and keeps a Buy rating on the shares. The firm said they reported a Q3 miss but as they head into Q4 management expects organic sales to return to growth due to strength in their “Right to Win” portfolio and expectations to grow international.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care: Hold Rating Amidst Valuation Challenges and Future Growth Pressures
- Edgewell upgraded to Equal Weight from Underweight at Morgan Stanley
- Edgewell Personal Care Reports Q3 2025 Earnings
- Edgewell Personal Care Co Faces Challenges Amid Growth
- Edgewell Personal Care reports Q3 adjusted EPS 92c, consensus 99c
